Skip to content

ABVC BioPharma, Inc.

ABVC

CIK 0001173313

← back to feed
Revenue (TTM)
$1.3M
+234.3% YoY Q1 May 2026
Net Income (TTM)
−$6.7M
−61.3% YoY Q1 May 2026
EPS Diluted (TTM)
−$0.34
+7.1% YoY Q1 May 2026
Gross Margin
99.9%
Q1 May 2026
Operating Margin
-500.5%
Q1 May 2026
Net Margin
-514.1%
Q1 May 2026
Free Cash Flow (TTM)
−$3.91M
Q1 May 2026
Cash
$140.32K
Q1 May 2026
Total Debt
$213.14K
Q1 May 2026
Shares Outstanding
26M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings